Which cough syrup works best? new study puts three popular options to the test
NCT ID NCT06907355
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed trial tested three common cough treatments—levodropropizine, a codeine combination, and ivy leaf extract—against a placebo in 196 adults with acute cough from upper respiratory infections. Participants took the medicine three times a day for four days. The main goal was to see how much cough severity changed after 48 hours. The results could help guide which over-the-counter or prescription cough medicine is most effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Levodropropizine, Codeine (with Pseudoephedrine and Chlorphenamine), Ivy Leaf (Hedera Helix Extract)
- What this could lead to
- If this trial shows one treatment works better than the others, it could help doctors choose the most effective cough medicine for common colds.
- What could go wrong
- This is a completed Phase 4 trial with 196 participants, so results are already in. However, the findings may not apply to everyone, and any benefits might be small compared to placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UPPER RESP TRACT INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Pontificia Universidad Catolica de Chile
Santiago, Chile
More trials for these conditions
Other studies related to the condition(s) this trial covers.